JP4034830B2 - Cell separation material - Google Patents

Cell separation material Download PDF

Info

Publication number
JP4034830B2
JP4034830B2 JP28854393A JP28854393A JP4034830B2 JP 4034830 B2 JP4034830 B2 JP 4034830B2 JP 28854393 A JP28854393 A JP 28854393A JP 28854393 A JP28854393 A JP 28854393A JP 4034830 B2 JP4034830 B2 JP 4034830B2
Authority
JP
Japan
Prior art keywords
blood
filter
gel
platelets
leukocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP28854393A
Other languages
Japanese (ja)
Other versions
JPH07136508A (en
Inventor
光夫 岡野
誠人 大西
建 建部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellseed Inc
Original Assignee
Cellseed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellseed Inc filed Critical Cellseed Inc
Priority to JP28854393A priority Critical patent/JP4034830B2/en
Publication of JPH07136508A publication Critical patent/JPH07136508A/en
Application granted granted Critical
Publication of JP4034830B2 publication Critical patent/JP4034830B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

【0001】
【産業上の利用分野】
本発明は、血液、血液製剤あるいは血球を含む液体より血小板あるいは白血球を分離する材料に関するものである。
【0002】
【従来の技術】
血液、血液製剤あるいは血球を含む液体より血小板あるいは白血球を分離する方法としては、遠心分離法、フィルターによる濾過法がある。主に血小板を全血から分離・回収するために用いられる遠心分離法は、血液バッグ中の血液を遠心する方法と、血液成分分離装置による方法があり、バッグによる遠心はコストが安く、ドナーへの負担が少なく、機械トラブルが少ないなどのメリットがあるが、遠心分離、分離バッグへの移し変えの操作が煩雑で時間がかかるなどの欠点があった。
【0003】
また、血液成分分離装置は操作が全自動になっており、採血者の操作は簡単になったが、装置のコストが高く、またドナーの拘束時間が長いなどの欠点があった。更に、遠心分離法に共通の欠点として、血球を比重の差のみで分けているため血球の選択性が低く、目的以外の血球の混入があった。
【0004】
主に白血球を血液製剤から捕捉・回収するために用いられるフィルターによる濾過法については多くの特許が開示されているが(特公昭58−54125号、特公昭58−54130号、特公昭61−39060号、特公昭63−26089号など)、どの方法も濾材により白血球あるいはリンパ球を捕捉したのち血球を洗い出す方法であり、濾材と血球の相互作用を変えずにこのような操作を行うため血球の回収率、機能保持率が低く満足出来るものではなかった。
【0005】
更に、これらの欠点を解決する方法として、外部からの刺激に応じて血球との親和性が変化する高分子ゲルに血球を吸着させ、外部刺激により血球とゲルの親和性を失わせて血球を回収する試みがあるが、ゲル単体では強度が弱く、また有効に利用出来る表面積が少ないといった欠点があった。
【0006】
【発明が解決しようとする課題】
本発明は、上記のような問題点を解決するためになされたものであり、煩雑な操作、コストの高い装置が不要で、目的以外の血球の混入がなく、ドナーへの負担が少なく、高い選択性で高回収率と機能保持率を確保した細胞分離用材料を提供することを目的とする。
【0007】
【課題を解決するための手段】
本発明者らは以上のような点を鑑み、鋭意研究を重ねた結果、細胞に対する親和性が外部からの刺激に応じて変化する高分子ゲルを表面に被覆した高分子多孔体または繊維集合体を細胞分離用材料として用いることで上記課題を解決出来ることを見出した。
【0008】
即ち、本発明は血液あるいは血液製剤より血小板あるいは白血球を選択的に捕捉・回収するフィルターに供する材料であって、基材として平均孔径が1〜60μmの高分子多孔体または繊維集合体を用い、該基材の表面に温度感応性、光感応性、電気感応性、などの性質を持った高分子ゲルを被覆し、血小板あるいは白血球との親和性をこれらのゲルの膨潤・収縮などによって変化させて、該血小板あるいは白血球を吸・脱着させるものである。
【0009】
基材に用いる高分子多孔体としては、ポリウレタン、ポリフッ化ビニリデン、ポリサルホン又はポリエーテルサルホン、ポリアミド、ポリエステル、ポリエーテルポリアミド、エチレンビニルアルコール、ポリエチレン、ポリプロピレン、ポリビニルホルマール、ポリスチレンなどの連続気孔を有する多孔体を形成出来る材料であれば何を用いても構わない。
【0010】
基材に繊維集合体を用いる場合は、ポリアミド、ポリエステル、ポリアクリロニトリル系、ポリテトラフルオロエチレンなどの有機合成繊維、アセテートなどの半合成繊維、銅アンモニアレーヨンなどの再生人造繊維、ガラス繊維などの無機繊維、綿、絹糸、羊毛などの天然繊維を用いることが出来る。
【0011】
基材の形態としては、多孔体からなる平膜、中空糸膜、などの膜状物、あるいは単に多孔体の塊状物、繊維の集合体、繊維を不織布、織布、編み物にしたものなどがあり、目的の血球を分離回収するのに適した形態であればどの様な形態でも構わないが、一般に白血球除去フィルターに用いられているような繊維カラム・繊維フィルター・多孔体フィルターが使いやすい。
【0012】
該基材の表面に被覆する高分子ゲルは、以下のポリマーまたはコポリマーにより得られる。使用しうるポリマーは、これらの化合物に限定されるものではないが、温度感応性の場合、例えば、アクリルアミドまたは(メタ)アクリルアミド化合物、N−アクリル置換(メタ)アクリルアミド誘導体、N,N−ジアルキル置換(メタ)アクリルアミド誘導体、N−ヘテロ環状基置換(メタ)アクリルアミド誘導体、ビニルエーテル誘導体などの重合体または共重合体が用いられる。また、ポリメタクリル酸−ポリエチレングリコールの様にコンプレックス形成を利用することも出来る。
【0013】
光感応性の場合は、例えば、アゾベンゼン基をもつポリヒドロキシエチルメタクリレートのように光異性化を起こす色素と含水ゲルを結合させたもの、トリフェニルメタンロイコハイドロオキシドのビニル誘導体とアクリルアミド系化合物の共重合体のように光イオン解離する感応基をもつイオンゲル、スピロベンゾピランを含むN−イソプロピルアクリルアミドゲルの様に疎水性相互作用が光変化するものなどが用いられる。
【0014】
電気感応性の場合は、例えば、アクリルアミドゲルの一部を加水分解したものや、ポリメタクリル酸、2−アクリルアミド−2−メチルプロパンスルホン酸−2−ヒドロキシエチル共重合体の様にイオン解離基を持たせたものなどが用いられる。
【0015】
また、光イオン解離する感応基をもつイオンゲルの様に光と電気の両者に応答するようなゲルの場合、両方の刺激を利用することも出来る。
【0016】
また、血球とゲルとの親和性を調節する場合や、高分子ゲルと基材多孔体または繊維集合体との相互作用を調節する必要がある場合は、高分子ゲルの性質を変えるために、上記以外のモノマー類との共重合、ポリマー同士のグラフトまたは共重合、あるいはポリマー、コポリマーの混合物を用いても良い。また、ポリマー本来の性質を損なわない範囲で架橋することも可能である。
【0017】
これらのゲルの高分子多孔体または繊維集合体への被覆方法は、化学的な反応または物理的相互作用を単独または併用して用いることが出来る。化学的な反応により結合させる方法としては、例えば電子線照射、ガンマ線照射、紫外線照射、プラズマ処理、コロナ処理、あるいは基材とゲルが適当な反応性官能基を有する場合には、ラジカル反応、アニオン反応、カチオン反応等の一般に用いられる有機反応を用いることが出来る。物理的相互作用を利用する方法としては、例えば、ゲル単独または基材との相溶性が良いマトリックスを媒体として、コーティング、混練等の物理的吸着を用いる方法がある。
【0018】
このようにして得られた細胞分離用材料は、基材の形態に応じて、平膜や中空糸膜などのモジュール、多孔体の塊状物、繊維の集合体を入れたカラム、不織布や織布あるいは編み物を収容したモジュールなどの容器に収容されて、細胞分離フィルターとして用いられる。容器の形態は、一般に白血球除去フィルターに用いられているような繊維カラム・繊維フィルター・多孔体フィルターが使いやすいが、目的の血球を分離回収するのに適した形態であればどの様な形態でも構わない。
【0019】
該細胞分離フィルターは目的とする血球を含む血液の入口と出口をもつ。また、血液の入口と出口は同じものを兼ねても良い。また、分離回収する血球の出口を別に設けても良いし、生理食塩水などのリンス液を導入する口を設けても良い。更に、温度、光、電気、など細胞分離用材料の応答性に対応した信号を与える装置が該細胞分離フィルター近くに備わる。ここで、血液と接触する回路及び細胞分離フィルターは使い捨てが望ましいが、これらの信号を与える装置は細胞分離フィルターを支持するホルダー等と一体化することが装置を小型化するために望ましい。
【0020】
この細胞分離フィルターを含む血球分離システムは、血液保存バッグ間に導入して、バッグからバッグへ血液を移す際に分離操作を行うことが出来る。白血球除去フィルターや、血漿分離装置などとも組み合わせて用いることも出来る。また、採血回路、抗凝固剤添加回路、血球保存バッグと組み合わせて血小板フェレーシスあるいは白血球フェレーシス用として用いることも出来る。
【0021】
【作用】
本発明の作用を温度感応性ゲルを用いたフィルターで血小板を分離・回収する例で説明する。
【0022】
フィルターに血小板を含む液体を導入する際は、N−プロピルアクリルアミドゲルが収縮状態の40℃に保っておく。一般にゲルは収縮した状態では膨潤した状態に比べて疎水性であるため、血小板が濾材表面の該ゲルに吸着する。この場合、血小板がその機能を失う程には変形しない程度に吸着する様ゲルを調整しておく。処理すべき液体を全てフィルターで濾過した後、ゲルが膨潤するような30℃に設定する。ゲルは膨潤することにより親水性となり、血小板との相互作用が弱まり血小板が溶離してくる。このとき必要であれば適当な溶離液をフィルターに導入しても良い。
【0023】
この方法によればバッグを遠心する場合の様に、操作が煩雑で時間がかかることがなく、また、血液分離装置の様に大きくコストの高い装置を使うことがなく、純度の高い血小板を得ることが出来る。また、同様の方法で白血球を分離・回収することもでき、従来の濾材と白血球の親和性を変化させない方法と比べて高い純度と回収率を得ることが出来る。更に、血小板と白血球の濾材への親和性の差を用いれば、両者の親和性が高い状態、一方のみの親和性が高い状態、両者の親和性が低い状態という3段階の状態変化により、ひとつのフィルターで2種類の血球を分離・回収することも可能である。
【0024】
【実施例】
厚さ7.2mm、平均孔径が3μmのポリウレタン多孔質膜にN−プロピルアクリルアミド水溶液を含ませ、乾燥後、ガンマ線照射を行い水不溶性ゲルを生成させた。この膜を直径47mmの円に打ち抜いてフィルターホルダーにはさみ込み、フィルター出入り口に塩ビのチューブを接続した。フィルターを40℃の恒温槽中に置いた状態で50mlのヒト保存血(CPD入り)をローラーポンプで毎分0.6mlの速度で送り込み、フィルターより出てきた血液を採取した。全ての血液が回収された後、フィルターを25℃の恒温槽中に置き、今度は生理食塩水50mlを同じ速度で送り込み、フィルターより出てきた液を採取した。
【0025】
濾過前のヒト保存血、濾過後のヒト保存血、フィルターを通ってきた生理食塩水中の血小板数はそれぞれ、23万、2.2万、18.6万(個/マイクロリットル)であった。
【0026】
【発明の効果】
本発明は、濾過・リンスおよび温度刺激調整という簡単な操作で、高い細胞分離・回収を行うことが出来た。
[0001]
[Industrial application fields]
The present invention relates to a material for separating platelets or leukocytes from blood, blood products or a liquid containing blood cells.
[0002]
[Prior art]
As a method for separating platelets or leukocytes from blood, blood products or a liquid containing blood cells, there are a centrifugal separation method and a filtration method using a filter. Centrifugation methods mainly used to separate and collect platelets from whole blood include a method of centrifuging blood in a blood bag and a method using a blood component separation device. However, there are disadvantages such as complicated and time-consuming operations for centrifugal separation and transfer to a separation bag.
[0003]
In addition, the blood component separation apparatus is fully automatic, and the operation of the blood sampler is simplified. However, there are drawbacks such as a high cost of the apparatus and a long donor restraint time. Furthermore, as a common drawback of the centrifugal separation method, blood cells are separated only by the difference in specific gravity, so the selectivity of blood cells is low, and blood cells other than the intended purpose are mixed.
[0004]
Many patents have been disclosed regarding filtration methods using filters mainly used for capturing and collecting leukocytes from blood products (Japanese Patent Publication Nos. 58-54125, 58-54130, 61-39060). No. 63, JP-B-63-26089, etc.), all methods are methods of washing blood cells after capturing leukocytes or lymphocytes with a filter medium, and this operation is performed without changing the interaction between the filter medium and blood cells. The recovery and function retention were low and not satisfactory.
[0005]
Furthermore, as a method of solving these disadvantages, blood cells are adsorbed on a polymer gel whose affinity with blood cells changes according to external stimuli, and the blood cells are lost by losing the affinity between blood cells and gel by external stimuli. Although there is an attempt to recover, the gel alone has the disadvantages that the strength is weak and the surface area that can be effectively used is small.
[0006]
[Problems to be solved by the invention]
The present invention has been made in order to solve the above-described problems, and does not require a complicated operation and a high-cost device, does not contain blood cells other than the intended purpose, has a low burden on the donor, and is high. An object of the present invention is to provide a cell separation material that is selective and ensures high recovery and function retention.
[0007]
[Means for Solving the Problems]
In view of the above points, the present inventors have conducted extensive research, and as a result, the polymer porous body or the fiber assembly in which the surface is coated with a polymer gel whose affinity for cells changes according to external stimuli. It has been found that the above problems can be solved by using as a cell separation material.
[0008]
That is, the present invention is a material used for a filter that selectively captures and collects platelets or leukocytes from blood or blood products, and uses a polymer porous body or fiber assembly having an average pore diameter of 1 to 60 μm as a base material, The surface of the base material is coated with a polymer gel having properties such as temperature sensitivity, light sensitivity, and electrical sensitivity, and the affinity with platelets or leukocytes is changed by swelling / contraction of these gels. Thus, the platelets or leukocytes are absorbed and desorbed.
[0009]
The porous polymer used for the substrate has continuous pores such as polyurethane, polyvinylidene fluoride, polysulfone or polyethersulfone, polyamide, polyester, polyether polyamide, ethylene vinyl alcohol, polyethylene, polypropylene, polyvinyl formal, polystyrene, etc. Any material can be used as long as it is a material capable of forming a porous body.
[0010]
When using a fiber assembly as the base material, organic synthetic fibers such as polyamide, polyester, polyacrylonitrile, polytetrafluoroethylene, semi-synthetic fibers such as acetate, recycled artificial fibers such as copper ammonia rayon, and inorganic such as glass fibers Natural fibers such as fiber, cotton, silk, and wool can be used.
[0011]
As the form of the substrate, there are membranes such as flat membranes and hollow fiber membranes made of porous bodies, or simply lumps of porous bodies, aggregates of fibers, fibers made of nonwoven fabrics, woven fabrics, knitted fabrics, etc. However, any form suitable for separating and collecting the target blood cells may be used, but a fiber column, a fiber filter, and a porous filter, which are generally used for leukocyte removal filters, are easy to use.
[0012]
The polymer gel coated on the surface of the substrate is obtained by the following polymer or copolymer. Polymers that can be used are not limited to these compounds, but in the case of temperature sensitivity, for example, acrylamide or (meth) acrylamide compounds, N-acryl substituted (meth) acrylamide derivatives, N, N-dialkyl substituted Polymers or copolymers such as (meth) acrylamide derivatives, N-heterocyclic group-substituted (meth) acrylamide derivatives, and vinyl ether derivatives are used. Moreover, complex formation can also be utilized like polymethacrylic acid-polyethylene glycol.
[0013]
In the case of photosensitivity, for example, polyhydroxyethyl methacrylate having an azobenzene group, which is a combination of a dye that causes photoisomerization and a hydrogel, a vinyl derivative of triphenylmethane leuco hydroxide and an acrylamide compound. An ion gel having a sensitive group capable of photoion dissociation, such as a polymer, or an N-isopropylacrylamide gel containing spirobenzopyran, in which hydrophobic interaction is photochanged, is used.
[0014]
In the case of electrosensitivity, for example, an ionic dissociation group is formed like a hydrolyzed part of acrylamide gel or polymethacrylic acid or 2-acrylamido-2-methylpropanesulfonic acid-2-hydroxyethyl copolymer. Something you have used is used.
[0015]
In addition, in the case of a gel that responds to both light and electricity, such as an ion gel having a sensitive group that undergoes photoion dissociation, both stimuli can be used.
[0016]
In addition, when adjusting the affinity between blood cells and gel, or when it is necessary to adjust the interaction between the polymer gel and the porous substrate or fiber assembly, in order to change the properties of the polymer gel, Copolymerization with monomers other than those described above, grafting or copolymerization of polymers, or a mixture of polymers and copolymers may be used. It is also possible to crosslink within a range that does not impair the original properties of the polymer.
[0017]
The method of coating these gels on the polymer porous body or fiber assembly can be used alone or in combination with a chemical reaction or a physical interaction. Examples of the method of bonding by chemical reaction include electron beam irradiation, gamma ray irradiation, ultraviolet irradiation, plasma treatment, corona treatment, or radical reaction, anion when the substrate and the gel have appropriate reactive functional groups. Commonly used organic reactions such as reactions and cation reactions can be used. As a method utilizing physical interaction, for example, there is a method using physical adsorption such as coating or kneading using a gel alone or a matrix having good compatibility with a substrate as a medium.
[0018]
The cell separation material obtained in this manner is a module such as a flat membrane or a hollow fiber membrane, a porous mass, a column containing an aggregate of fibers, a nonwoven fabric or a woven fabric, depending on the form of the substrate. Or it accommodates in containers, such as a module which accommodated knitting, and is used as a cell separation filter. The form of the container is easy to use a fiber column, fiber filter, or porous body filter that is generally used for leukocyte removal filters, but any form that is suitable for separating and collecting the target blood cells can be used. I do not care.
[0019]
The cell separation filter has an inlet and an outlet for blood containing a target blood cell. In addition, the blood inlet and outlet may be the same. Further, an outlet for blood cells to be separated and recovered may be provided separately, or a port for introducing a rinsing solution such as physiological saline may be provided. Furthermore, a device for providing a signal corresponding to the responsiveness of the cell separation material such as temperature, light, electricity, etc. is provided near the cell separation filter. Here, the circuit that contacts the blood and the cell separation filter are desirably disposable, but it is desirable that the device for providing these signals be integrated with a holder or the like that supports the cell separation filter in order to miniaturize the device.
[0020]
A blood cell separation system including this cell separation filter can be introduced between blood storage bags to perform a separation operation when transferring blood from the bag to the bag. It can also be used in combination with a leukocyte removal filter or plasma separator. In addition, it can be used for platelet pheresis or leukocyte pheresis in combination with a blood collection circuit, an anticoagulant addition circuit, and a blood cell storage bag.
[0021]
[Action]
The operation of the present invention will be described with reference to an example in which platelets are separated and collected by a filter using a temperature sensitive gel.
[0022]
When introducing a liquid containing platelets into the filter, the N-propylacrylamide gel is kept at 40 ° C. in a contracted state. In general, since the gel is more hydrophobic in the contracted state than in the swollen state, the platelets adsorb to the gel on the surface of the filter medium. In this case, the gel is adjusted so that the platelet is adsorbed to such an extent that it does not deform to such an extent that it loses its function. After all the liquid to be treated is filtered through a filter, the temperature is set to 30 ° C. so that the gel swells. When the gel swells, it becomes hydrophilic, the interaction with platelets weakens, and platelets elute. At this time, if necessary, an appropriate eluent may be introduced into the filter.
[0023]
According to this method, the operation is not complicated and time-consuming as in the case of centrifuging the bag, and high-purity platelets are obtained without using a large and expensive device such as a blood separation device. I can do it. In addition, leukocytes can be separated and collected by the same method, and high purity and recovery rate can be obtained as compared with the conventional method in which the affinity between the filter medium and leukocytes is not changed. Furthermore, if the difference in the affinity of platelets and leukocytes for the filter medium is used, there will be one state change due to a three-stage state change: a state in which both have a high affinity, a state in which only one has a high affinity, and a state in which both have a low affinity. It is also possible to separate and collect two types of blood cells with this filter.
[0024]
【Example】
A polyurethane porous membrane having a thickness of 7.2 mm and an average pore diameter of 3 μm was mixed with an N-propylacrylamide aqueous solution, dried, and then irradiated with gamma rays to form a water-insoluble gel. This membrane was punched out into a circle with a diameter of 47 mm and sandwiched between filter holders, and a PVC tube was connected to the filter entrance. With the filter placed in a constant temperature bath at 40 ° C., 50 ml of human stored blood (with CPD) was fed at a rate of 0.6 ml / min with a roller pump, and the blood that came out of the filter was collected. After all the blood was collected, the filter was placed in a thermostatic bath at 25 ° C., and 50 ml of physiological saline was then fed at the same speed, and the liquid coming out of the filter was collected.
[0025]
The number of platelets in human stored blood before filtration, human stored blood after filtration, and physiological saline that passed through the filter was 230,000, 220,000, and 186,000 (pieces / microliter), respectively.
[0026]
【The invention's effect】
In the present invention, high cell separation / recovery could be performed by simple operations such as filtration / rinsing and temperature stimulation adjustment.

Claims (1)

血小板および白血球に対する親和性が外部からの刺激に応じて変化する高分子ゲルを表面に被覆した高分子多孔体または繊維集合体からなり、血小板と白血球の濾材への親和性の差を利用したことを特徴とする、血液または血液製剤から血小板あるいは白血球を分離するための材料。 It consists of a polymer porous body or a fiber assembly coated with a polymer gel whose affinity to platelets and leukocytes changes in response to external stimuli, and uses the difference in the affinity of platelets and leukocytes to the filter medium A material for separating platelets or leukocytes from blood or blood products .
JP28854393A 1993-11-17 1993-11-17 Cell separation material Expired - Fee Related JP4034830B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28854393A JP4034830B2 (en) 1993-11-17 1993-11-17 Cell separation material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28854393A JP4034830B2 (en) 1993-11-17 1993-11-17 Cell separation material

Publications (2)

Publication Number Publication Date
JPH07136508A JPH07136508A (en) 1995-05-30
JP4034830B2 true JP4034830B2 (en) 2008-01-16

Family

ID=17731607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28854393A Expired - Fee Related JP4034830B2 (en) 1993-11-17 1993-11-17 Cell separation material

Country Status (1)

Country Link
JP (1) JP4034830B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954971A (en) * 1997-01-07 1999-09-21 Haemonetics Corporation Pumped-filter blood-processing apparatus and methods
AU3895100A (en) * 1999-03-17 2000-10-04 Foster-Miller Inc. Responsive gels and methods of use thereof
JP4536879B2 (en) * 1999-07-29 2010-09-01 学校法人 関西大学 Method and apparatus for removing organic substance in liquid
JP4572408B2 (en) * 2005-10-14 2010-11-04 独立行政法人産業技術総合研究所 Photoresponsive gel material, microvalve and microchip
WO2007063736A1 (en) * 2005-11-29 2007-06-07 National Institute Of Advanced Industrial Science And Technology Microarray chip, cell array using same and method for producing same
JP7269594B2 (en) * 2018-09-27 2023-05-09 株式会社村田製作所 Cell separation filter and cell separation method

Also Published As

Publication number Publication date
JPH07136508A (en) 1995-05-30

Similar Documents

Publication Publication Date Title
US5498336A (en) Leukocyte-removing filter and leukocyte-removing apparatus furnished therewith
US5286449A (en) Adsorber module for whole blood treatment and an adsorber apparatus containing the adsorber module
EP1156067B1 (en) Blood filter with (meth)acrylic copolymers comprising glycolether and aminoalkyl units
EP1886704B1 (en) Adsorbent and column for extracorporeal circulation
US5407581A (en) Filter medium having a limited surface negative charge for treating a blood material
CA1102710A (en) Membrane unit and device for cleansing blood
JP4992120B2 (en) Virus and leukocyte selective removal material and use thereof
US4206050A (en) Membrane unit and apparatus for removing metabolite contaminants from blood
EP0341413B2 (en) An adsorber module and adsorber apparatus for whole blood treatment
US7156240B2 (en) Filter for processing blood and process for producing the same
JP3641301B2 (en) Stimulation response type separation material and separation purification method
EP1016426B1 (en) Leukocyte-removing filter material
KR20020059664A (en) Filter for Selectively Removing Leukocyte
JP4034830B2 (en) Cell separation material
JP3124565B2 (en) Leukocyte removal filter and leukocyte removal device
CN105307743A (en) Chromatography media for purifying vaccines and viruses
JP3741320B2 (en) Leukocyte selective removal filter material
JP4997770B2 (en) Adsorber
KR101420036B1 (en) Substrate for ligand immobilization and method for producing same
JP3270125B2 (en) Leukocyte trapping material
JPH0260660A (en) Adsorbent for treating body fluid
JP3208132B2 (en) Blood component separation method
JPH06312017A (en) Adsorbent of endotoxin and/o cytokine and method for obtaining purified blood using the same
JPH067432A (en) Blood constituent separating apparatus
JPH06296860A (en) Porous support and adsorption material

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20031202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040204

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20040426

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040525

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20040827

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070919

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20071026

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101102

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111102

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111102

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121102

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees